4. Avandia - Top 10 Warnings and Recalls

Drug: Avandia

2006 sales: $3.4 billion

Manufacturer: GlaxoSmithKline

Safety concern: “black box;” heart failure, heart attack

Related Articles:
> New Avandia warning 'a muddle'. Report
> Avandia warning, comeback imminent? Report
> Avandia cleared FDA by one vote. Report
> Avandia, Actos don't boost death risk. Report
> FDA adds to drumbeat of bad news for Avandia. Report
> Expert committee says Avandia should stay. Report
> FDA expert wants Avandia withdrawn. Report
> Docs shunning Avandia in wake of safety study. Report
> Avandia risks exposed under deal to post data. Report

4. Avandia - Top 10 Warnings and Recalls
Read more on

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.